Showing results (531-540 of 742) with videos related to

Sort By:
Pageof 75
Science Translational Medicine|October 12, 2018
The mechanosensitive ion channel Piezo2 mediates sensitivity to mechanical pain in miceSwetha E Murthy, Meaghan C Loud, Ihab Daou, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
The Journal of Infectious Diseases|February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapyMegan Crane, Ben Oliver, Gail Matthews, et al.
Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 1999
A new role for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle controlV A Botchkarev, N V Botchkareva, P Welker, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
AIDS (London, England)|November 6, 2013
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cellsFiona Wightman, Hao K Lu, Ajantha E Solomon, et al.
AIDS (London, England)|January 24, 2014
Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionVivek Naranbhai, Christina C Chang, Raveshni Durgiah, et al.
Journal of Virology|February 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferationJared Stern, Rory A Shepherd, Youry Kim, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
Pageof 75